The Industry Standing Group (ISG) is a forum for interaction that has been established as part of the EMA’s continuous improvement for engagement with industry stakeholders supply chain of human, veterinary and medical device sectors...
EMA has recommended granting a conditional marketing authorisation in the European Union (EU) for Anktiva (nogapendekin alfa inbakicept) to treat adults with a type of bladder cancer that affects the lining of the bladder (non-muscle invasive bladder...
European Medicines Agency (EMA) and Heads of Medicines Agencies (HMA) were hosting the first EMA/HMA multi-stakeholder forum on EudraVigilance and signal Detection. The Forum’s main objectives were to inform stakeholders on ongoing and forthcoming developments...
Enpr-EMA’s annual meeting is a unique opportunity for networks and other stakeholders of paediatric clinical trials, such as health care professionals, parents, carers, patient representatives as well as medicine developers and regulators, to learn about...
The 2025 annual meeting of the members of the European network of paediatric research at the EMA (Enpr-EMA) and its Coordinating Group focused on recent Enpr-EMA developments, collaboration with ACT EU, and future strategic priorities....
This was the fifteenth in a series of regular meetings between regulators and representatives of industry stakeholder organisations. It addressed all areas of evidence generation along the medicine’s life-cycle and related to development support activities,...
The 6th EMA-AESGP bilateral meeting is organised in the context of the EMA annual bilateral meetings with industry stakeholder organisations. The purpose of the meeting is to exchange views and promote dialogue on topics of...
The seventh EMA-EUROPABIO bilateral meeting is organised in the context of the EMA annual bilateral meetings with industry stakeholder organisations. The purpose of the meeting is to exchange views and promote dialogue on topics of...
This meeting between European Medicines Agency (EMA) and Medicines for Europe is organised in the context of the EMA annual bilateral meetings with industry stakeholder organisations. The purpose of the meeting is to exchange views...
The Industry Standing Group (ISG) is a forum for interaction that has been established as part of the EMA’s continuous improvement for engagement with industry stakeholders supply chain of human, veterinary and medical device sectors...
